JP2008186039A - Subject recruitment method, mediator server, software, and recording medium - Google Patents

Subject recruitment method, mediator server, software, and recording medium Download PDF

Info

Publication number
JP2008186039A
JP2008186039A JP2006355661A JP2006355661A JP2008186039A JP 2008186039 A JP2008186039 A JP 2008186039A JP 2006355661 A JP2006355661 A JP 2006355661A JP 2006355661 A JP2006355661 A JP 2006355661A JP 2008186039 A JP2008186039 A JP 2008186039A
Authority
JP
Japan
Prior art keywords
applicant
clinical trial
trial
question
participation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006355661A
Other languages
Japanese (ja)
Other versions
JP4697972B2 (en
Inventor
Masafumi Hirano
方史 平野
Yuki Mihara
酉木 三原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUMA CORP
Original Assignee
HUMA CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUMA CORP filed Critical HUMA CORP
Priority to JP2006355661A priority Critical patent/JP4697972B2/en
Publication of JP2008186039A publication Critical patent/JP2008186039A/en
Application granted granted Critical
Publication of JP4697972B2 publication Critical patent/JP4697972B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a subject recruitment method capable of efficiently selecting proper subjects highly precisely for every clinical trial. <P>SOLUTION: A server of a mediator 10 has: a step (a) of presenting a recruitment image in which the mediator 10 shows recruitment contents through the Internet 18 to urge a wisher 16 to participate in a clinical trial to register; a step (b) of receiving a registration of an applicant 16, presenting clinical trial conditions to the applicant 16 and urging the applicant 16 to participate in the application; a step (c) of receiving a participation application of the applicant 16, sequentially presenting a detailed question corresponding to the clinical trial to the applicant 16, receiving an answer of the question, and sequentially repeating an operation for making the answer uncorrectable for each question; a step (d) of determining whether the applicant 16 is suitable to the clinical trial, preparing a list of clinical trial candidates from the results and allowing a clinical trial performer 14 to browse the list; and a step (e) of notifying the participation applicant of determination results of the step (d). <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

この発明は、食品における治験、医薬品・対象疾患における治験、化粧品の治験などに自発的に参加する被験者を募集し、治験条件に適した被験者を選出するための被験者募集方法と、この方法に用いる仲介者のサーバと、ソフトウェアと、ソフトウェアを記録した記録媒体とに関するものである。   The present invention recruits subjects who voluntarily participate in clinical trials for foods, clinical trials for pharmaceuticals and target diseases, clinical trials for cosmetics, and the like, and a subject recruiting method for selecting subjects suitable for the clinical trial conditions and this method The present invention relates to an intermediary server, software, and a recording medium on which the software is recorded.

保健機能食品、サプリメント(栄養補助品)、健康食品、医薬品、化粧品、医療機器などの有効性と安全性を確認するために臨床試験(以下治験ともいう)が行われている。この治験は、食品や化粧品、医薬品などの開発者・販売者などの治験依頼者が実際に治験を行う医療機関などの治験実施者(治験実施機関)を決定し、また治験依頼者自身が治験実施者となって、治験実施者が被験者に対して種々の治験を行うものである。   Clinical trials (hereinafter also referred to as clinical trials) are being conducted to confirm the effectiveness and safety of health functional foods, supplements (nutritional supplements), health foods, pharmaceuticals, cosmetics, medical devices, and the like. In this trial, a sponsor such as a developer or distributor of food, cosmetics, pharmaceuticals, etc., decides the trial investigator (clinical trial institution) such as a medical institution that actually conducts the clinical trial. The practitioner becomes a practitioner and the trial practitioner conducts various trials on the subject.

特開2002−41657JP2002-41657

被験者の選定方法として特許文献1(特に段落0078〜0083)には、被験者を広告、インターネット、口コミ、縁故などによって募集し、治験内容に対応する対象被験者集団を選定しスクリーニングし、被験者の納得、同意を得て選定することが示されている。ここに治験毎に収集確認すべき被験者情報は異なるから、被験者情報収集不足は極力避けなければならない。そこで特許文献1では短い会話の中で被験者と募集担当者との間で信頼関係を築き、質問の方法を適切に管理することが必要であるという(段落0082,0083)。   In Patent Document 1 (particularly paragraphs 0078 to 0083) as a method for selecting a subject, subjects are recruited by advertisement, the Internet, word-of-mouth, marginal relations, etc., a target subject group corresponding to the content of the trial is selected and screened, It is shown to select with consent. Since the subject information to be collected and confirmed here differs from trial to trial, lack of subject information collection should be avoided as much as possible. Therefore, in Patent Document 1, it is necessary to establish a trust relationship between the subject and the recruiter in a short conversation and to appropriately manage the questioning method (paragraphs 0082 and 0083).

このように従来は被験者を募集するに当たって被験者との会話を通して被験者情報を得るため、募集担当者との相性などにより取得情報の精度に不揃いが生じ易く治験条件に適合した被験者の選定精度が低下するという問題が生じる。また被験者毎に会話による質問・回答を繰り返すことになり、能率が悪いという問題が生じる。   As described above, in order to obtain the subject information through the conversation with the subject in recruiting the subject in the past, the accuracy of the obtained information is likely to be uneven due to compatibility with the recruiting person and the like, and the accuracy of selecting the subject suitable for the clinical trial condition is lowered. The problem arises. Moreover, the question and answer by conversation are repeated for each subject, and the problem that efficiency is bad arises.

この発明はこのような事情に鑑みなされたものであり、治験毎に適切な被験者を高い精度で能率良く選出することができる被験者募集方法を提供することを第1の目的とする。またこの方法の実施に直接使用する仲介者のサーバを提供することを第2の目的とする。またこの方法の実施に用いるソフトウェアと、このソフトウェアを記憶した記憶媒体を提供することを第3および第4の目的とする。   This invention is made | formed in view of such a situation, and makes it the 1st objective to provide the test subject recruitment method which can select an appropriate test subject with high precision efficiently for every clinical trial. A second object is to provide an intermediary server that is directly used to implement this method. It is a third and fourth object of the present invention to provide software used for implementing this method and a storage medium storing this software.

この発明によれば第1の目的は、治験実施者が行う治験に協力する被験者を紹介する仲介者が、インターネットを介して被験者を募集するための被験者募集方法において、前記仲介者のサーバは、a.仲介者が募集内容を示す募集画面をインターネットを介して提示し治験参加希望者に登録を促す工程、b.応募者の登録を受けて応募者に治験条件を提示し参加申込みを促す工程、c.応募者の参加申込みを受けて応募者に治験に対応する詳細な質問を逐次形式で提示しその回答を受けると共に前の回答を修正不可とする動作を1つの質問ごとに逐次繰り返す工程、d.応募者が前記治験に適合するか否かを判定しその結果から治験候補者のリストを作成し治験実施者による閲覧を可能にする工程、e.前記工程dの判定結果を参加申込者に連絡する工程、以上のa〜eの工程を有する被験者募集方法、により達成される。   According to the present invention, a first object is to provide a subject recruiting method for recruiting a subject via the Internet by a mediator who introduces a subject who cooperates in a clinical trial conducted by a trial practitioner. a. A step in which an intermediary presents a recruitment screen showing contents of recruitment via the Internet and prompts a trial applicant to register; b. Receiving the applicant's registration, presenting the clinical trial conditions to the applicant, and encouraging the application for participation; c. Receiving the applicant's application for participation, presenting detailed questions corresponding to the clinical trial to the applicant in a sequential format, receiving the answers, and repeating the operation of making the previous answer uncorrectable sequentially for each question; d. Determining whether the applicant is suitable for the clinical trial and creating a list of clinical trial candidates from the results to allow review by the clinical trial practitioner; e. This is achieved by the step of notifying the participation applicant of the determination result of the step d, the subject recruiting method having the above steps a to e.

第2の目的は、請求項1の方法に用いる仲介者のサーバであって、被験参加希望者の端末機に対し治験条件を示す治験者募集画面を提示し応募を促す募集画面提示部と、被験参加希望者の端末機から入力される登録申込信号を受付ける登録受付部と、登録申込信号を受け付けて治験参加希望者である応募者の端末機に治験条件を提示し治験参加を促す参加条件提示部と、応募者の端末機から入力される治験参加申込信号を受付ける参加申込み受付部と、参加申込信号を受け付けて治験に対応する詳細な質問を応募者の端末機に逐次形式で提示し回答を促すと共に前の回答を修正不可とする詳細質問提示部と、応募者が治験に適合するか否かを判定する適否判定部と、適合する応募者を被験候補者としてリストを作成し治験実施者による閲覧を可能にするリスト作成部と、前記適否判定部の判定結果を各治験参加申込者ごとにそれぞれ通知する判定結果通知部と、を備えることを特徴とする被験者募集仲介者のサーバ、により達成される。   A second purpose is a server of an intermediary used in the method of claim 1, a recruitment screen presenting section that presents a clinical trial recruitment screen showing clinical trial conditions to a terminal of a test participation applicant and urges application, Registration acceptance unit that accepts the registration application signal input from the terminal of the applicant who wants to participate, and participation conditions that accept the registration application signal and present the clinical trial conditions to the applicant's terminal that is the applicant for the clinical trial to encourage participation in the trial The presentation section, the participation application reception section that accepts the clinical trial participation application signal input from the applicant's terminal, and the detailed information corresponding to the clinical trial that accepts the participation application signal are presented to the applicant's terminal in a sequential format. A detailed question presentation unit that prompts responses and makes the previous response uncorrectable, a suitability determination unit that determines whether or not an applicant is suitable for a clinical trial, and creates a list with appropriate applicants as test candidates. Browse by the implementer And a determination result notifying unit for notifying the determination result of the suitability determining unit for each clinical trial applicant, respectively. .

第3の目的は、請求項1の動作を行うためのソフトウェア、により達成される。   The third object is achieved by software for performing the operation of claim 1.

第4の目的はこのソフトウェアを記憶した記憶媒体、により達成される。   The fourth object is achieved by a storage medium storing this software.

第1の発明によれば、応募者に対する治験内容の提示(工程a)、応募者の登録(工程b)、応募者が治験条件を見たうえで参加を申込み、この段階でさらに詳細な質問と回答を1問ごとに逐次繰り返し前の回答を修正できなくする(工程c)、というように応募者の反応に対応して段階的に詳細になる情報の送受を行い、応募者情報を得るようにしたので、治験ごとに適切な被験候補者を能率良く選出することができる。すなわち少なくとも募集段階(被験候補者選定段階)では、応募者と仲介者(募集担当者)との間で会話を行う必要がないから、選定基準を明確化できるからである。特に参加申込み後に提示する詳細な質問は、1問ごとに回答を得て前の回答を訂正できなくしてから逐次繰り返えすので(工程c)、言いかえれば一部の回答を飛ばす(回避させる)ことがなく、前の回答に意図的に合わせた不正直な回答が出にくくなり、多数の質問に矛盾点が有るか否かなど判断し易くなり、正直な被験応募者情報を確実に得て、被験候補者の選出精度を向上させることができるものである。   According to the first invention, presentation of the clinical trial contents to the applicant (process a), registration of the applicant (process b), the applicant applies for participation after viewing the clinical trial conditions, and more detailed questions at this stage In response to the applicant's reaction, detailed information is sent and received in stages to obtain the applicant information. Since it did in this way, a suitable test candidate can be selected efficiently for every clinical trial. That is, at least in the recruitment stage (test candidate selection stage), it is not necessary to have a conversation between the applicant and the intermediary (recruiter), so the selection criteria can be clarified. In particular, detailed questions to be presented after applying for participation will be repeated one by one after obtaining an answer for each question and making it impossible to correct the previous answer (step c). ), Making it difficult to make dishonest answers that are intentionally matched to previous answers, making it easier to determine whether or not there are inconsistencies in many questions, and ensuring honest test applicant information. Thus, the accuracy of selecting the test candidate can be improved.

第2の発明によれば、この第1の発明の実施に直接使用する仲介者のサーバが得られる。第3の発明によれば、請求項1の動作を行うためのソフトウェアが得られる。また第4の発明によれば、このソフトウェアを記憶した記憶媒体、例えば光ディスクが得られる。   According to the second aspect of the invention, an intermediary server that is used directly in the implementation of the first aspect of the invention is obtained. According to the third aspect, software for performing the operation of claim 1 is obtained. According to the fourth invention, a storage medium storing this software, for example, an optical disk is obtained.

請求項1の工程dでは、治験候補者リストは治験実施者がインターネットを介して仲介者のサーバにアクセスして閲覧してもよいが、仲介者がeメールやファクシミリや郵便などによって治験実施者に送り治験実施者が閲覧できるようにしてもよい。仲介者のサーバには、被験経験者の実績、例えば過去の治験における遅刻、無断欠席、連絡欠席、治験途中での脱落・中断、追跡調査への協力意欲などの過去の参加成績の実績を示すデータを設け、選出した被験候補者のリストにこの実績データに基づいた信頼性情報を合わせて出力するのがよい(請求項2)。この場合はこの信頼性情報によりそれぞれの被験者に対する信頼度を直ちに知ることができ、例えば治験実施者が治験者を選出したり治験を行う際の1つの有力な参考資料になる。   In step d of claim 1, the trial candidate list may be browsed by the trial practitioner by accessing the mediator's server via the Internet, but the trial practitioner by e-mail, facsimile, mail, etc. May be made available to the trial investigator for viewing. The mediator's server will show the results of past participants, such as past trial results such as late clinical trials, absence without notice, absence of contact, dropout / interruption during the trial, willingness to cooperate in follow-up studies, etc. It is preferable to provide data, and output reliability information based on the result data together with the list of selected test candidates (claim 2). In this case, the reliability information for each subject can be immediately known from this reliability information, and for example, it becomes one powerful reference material when the investigator selects the investigator or conducts the clinical trial.

工程cの詳細な質問の提示工程では、1問ごとに画面にして応募者の端末機に表示し、1問ごとの回答を待って次の質問に移行する(以下逐次形式ともいう)のがよい(請求項3)。このようにすれば質問ごとに独立画面に表示され、応募者に前後の質問事項の影響を受けずに回答させることができ、被験候補者情報の精度向上に一層適する。   In the detailed question presenting process of step c, each question is displayed on the applicant's terminal as a screen, and after waiting for an answer for each question, the process proceeds to the next question (hereinafter also referred to as a sequential format). (Claim 3) If it does in this way, it will be displayed on an independent screen for every question, an applicant can be made to answer without being influenced by the questions before and behind, and it is further suitable for improvement in accuracy of candidate information.

工程cでは、応募者に対して予め用意した詳細な質問を途中で中断することなく最後まで行うのがよい(請求項4)。すなわち質問の途中で応募者が治験条件に適合しないことが判明した時に質問を中断して募集手順を止めてしまうと、応募者が治験条件に適合しない回答を自ら知ることができ、何度でも応募を繰り返す不正が行われるおそれがあるからである。   In step c, detailed questions prepared in advance for the applicant may be conducted to the end without interruption (claim 4). In other words, if it is found that the applicant does not meet the study conditions in the middle of the question, the question can be interrupted and the recruitment procedure can be stopped. This is because there is a risk of fraud that repeats the application.

また工程eでは、判定結果を直ちに応募者に知らせず一定時間(例えば1〜24時間)後に連絡するのがよい(請求項5)。この場合には判定結果が不合格であった時に直ちに再応募することを防ぐことができ、応募を続けて何度も繰り返して質問・回答を学習し覚えてしまうという不正を防ぐことができる。   Further, in step e, it is preferable to notify the applicant immediately after a certain time (for example, 1 to 24 hours) without notifying the applicant of the determination result (claim 5). In this case, it is possible to prevent immediate re-application when the determination result is unacceptable, and it is possible to prevent an injustice that the application is repeated and repeated to learn and remember the question / answer.

第2の発明のサーバにおいて、さらに被験経験者の実績を示すデータ(実績データ)を記憶するメモリを持ち、選出した被験候補者のリストに対応する実績データを併せて表示すれば、被験候補者の信頼度を直ちに知ることができ便利である(請求項7)。   If the server of the second invention further has a memory for storing data (result data) indicating the results of the test experienced person, and if the result data corresponding to the list of selected test candidates is also displayed, the test candidate Therefore, it is convenient to immediately know the degree of reliability.

図1は本発明の実施例を示す構成図、図2はその全体動作の流れ図、図3は同じく被験者募集動作(手順)の流れ図、図4は同じく被験者募集動作の信号・データの送受を示す図、図5は仲介者のサーバの構成を示す図である。   FIG. 1 is a block diagram showing an embodiment of the present invention, FIG. 2 is a flowchart of the whole operation, FIG. 3 is a flowchart of a subject recruiting operation (procedure), and FIG. 4 is a signal / data transmission / reception of the subject recruiting operation. FIG. 5 and FIG. 5 are diagrams showing the configuration of the mediator server.

図1において符号10は仲介者のサーバ、12は治験依頼者(治験依頼機関)の端末機、14(14A、14B、…)は治験実施者(治験実施機関)の端末機、16(16A、16B、…)は応募者である被験希望者の端末機である。これらはインターネット18を介して互いに接続されている。なおここでは各端末機12、14、16は単に治験依頼者(機関)、治験実施者(機関)、被験希望者(応募者)ともいう。   In FIG. 1, reference numeral 10 denotes an intermediary server, 12 denotes a terminal of a trial requester (study requesting institution), 14 (14A, 14B,...) Denotes a terminal of the trial practitioner (trial conducting organization), 16 (16A, 16B,...) Is a terminal of an applicant who is an applicant. These are connected to each other via the Internet 18. Here, each of the terminals 12, 14, and 16 is also simply referred to as a clinical trial requester (institution), a clinical trial practitioner (institution), and a test applicant (applicant).

治験実施者の端末機14は、仲介者のサーバ10との接続を可能にする専用アプリケーションを持ち、サーバ10との間で送受信する被験希望者のデータの秘密保持機能を高めている。なおサーバ10と治験依頼者12、治験実施者14、被験希望者16との間でのデータの送受は、暗号通信やID(認証コード)やPW(パスワード)を用いることにより、秘密保持性を一層高めておくのがよい。   The investigator's terminal 14 has a dedicated application that enables connection with the broker's server 10, and enhances the function of maintaining the confidentiality of the data of the test candidate that is transmitted to and received from the server 10. In addition, the transmission and reception of data between the server 10 and the clinical trial requester 12, the clinical trial practitioner 14, and the prospective tester 16 is performed by using encryption communication, ID (authentication code), or PW (password), thereby maintaining confidentiality. It is better to keep it higher.

治験依頼者(医薬品などの生産者や販売者)12は、新薬や新しい食品、サプリメントなどを開発すると治験実施者14を決定する(図12のステップS100)。治験依頼者12が自ら治験実施者14となる場合(図2のステップS102)もある。治験依頼者12は治験の実施計画(デザイン)と概要を治験実施者14に提示し、決定する(ステップS104)。   The clinical trial requester (producer or seller of pharmaceuticals or the like) 12 determines the clinical trial practitioner 14 when developing a new drug, new food, supplement, or the like (step S100 in FIG. 12). In some cases, the clinical trial requester 12 becomes the clinical trial practitioner 14 (step S102 in FIG. 2). The clinical trial client 12 presents and determines the clinical trial implementation plan (design) and summary to the clinical trial practitioner 14 (step S104).

すなわち試験責任医師の選定、試験実施計画書の作成、実施医療機関の選定などを立案するものである。このデザイン作成において、治験依頼者12または実施者14は提携先医療機関倫理委員会(IRB)の承認を得るための資料を作成し、またIRB事務局を運営する(ステップS106)。その結果IRBの承認手続を完了すると、仲介者10は治験実施者14あるいは必要に応じて治験依頼者12と治験の打合せを行う(ステップS108)。この打合せでは、仲介者10と治験実施者14あるいは必要に応じて治験依頼者12と秘密保持契約や業務委受託契約を結び、治験(試験)概要を確認し、必要とする人数や日数や治験の困難性を考慮して費用の見積りを行う。   In other words, the selection of the investigator, the preparation of the study plan, the selection of the conducting medical institution, etc. are planned. In this design creation, the trial sponsor 12 or the practitioner 14 creates materials for obtaining approval from the partner medical institution ethics committee (IRB) and operates the IRB secretariat (step S106). As a result, when the IRB approval procedure is completed, the mediator 10 makes a meeting with the trial investigator 14 or the trial sponsor 12 as necessary (step S108). In this meeting, the intermediary 10 and the trial investigator 14 or, as necessary, the trial sponsor 12 and a confidentiality agreement or a business consignment agreement are concluded, the outline of the trial (examination) is confirmed, and the number of people, days, and clinical trials required. The cost is estimated in consideration of the difficulty.

次に本発明に係る被験者募集から被験候補者選出の手続に入る(ステップS110)が、この手順については後記する。このステップS110で最適な被験候補者のリストが出ると、治験実施者14は治験候補者の診察と検診を行い治験に適合するか否かを判断し、適合した候補者に対して治験の詳細な説明を行いこの治験に納得し承諾したことを互いに確認する(ステップS112)。その結果治験実施者14は候補者が治験に参加できるか否かを判定する(ステップS114)。この結果は仲介者10のサーバに送られ実績データとして記憶される(ステップS116)。またこの結果は応募者10に仲介者から送られる(ステップS118)。   Next, a procedure for selecting a test candidate is started from recruitment of subjects according to the present invention (step S110), which will be described later. When a list of optimal test candidates appears in this step S110, the trial investigator 14 examines and examines the trial candidates to determine whether or not they are suitable for the trial, and details the clinical trial for the matched candidates. After confirming that the clinical trial is accepted and accepted (step S112). As a result, the trial practitioner 14 determines whether the candidate can participate in the trial (step S114). This result is sent to the server of the broker 10 and stored as performance data (step S116). The result is sent from the intermediary to the applicant 10 (step S118).

治験実施者14はこの候補者のリストから抽出した被験者により治験を実行し治験の進行状況をモニタリングする(ステップS120)。この実施の実行と併行して仲介者10は被験者16の治験参加状況をが報告され記録される(ステップS122)。すなわち被験者の出欠状況、治験実施者14の指示を遵守して指示に従った投薬、報告等の行動をとっているか、などを監視するものである。   The trial practitioner 14 conducts a clinical trial using the subjects extracted from the candidate list and monitors the progress of the clinical trial (step S120). In parallel with this execution, the mediator 10 reports and records the clinical trial participation status of the subject 16 (step S122). In other words, the attendance status of the test subject, whether or not an action such as medication, reporting or the like is taken in accordance with the instruction in compliance with the instruction of the trial investigator 14 is monitored.

治験が終了すると、治験実施者14または仲介者10は治験結果を作成し、治験依頼者12に提出する(ステップS124)。また仲介者10は被験者16の治験参加状況を治験依頼者12または治験実施者14に報告し、仲介手数料などの料金を計算し請求する(ステップS126)。   When the clinical trial is completed, the trial investigator 14 or the mediator 10 creates a clinical trial result and submits it to the clinical trial requester 12 (step S124). Further, the mediator 10 reports the clinical trial participation status of the subject 16 to the clinical trial client 12 or the clinical trial practitioner 14, and calculates and charges a fee such as a mediation fee (step S126).

(被験者募集手順)
次に前記被験者募集の手順(ステップS110)を図3、4に基づいて説明する。仲介者10はそのホームページ(HP)に定常的に被験者募集を提示している(図3のステップS200)。従って応募者がこれを確認して(図4の(1))、事前に応募し登録(事前受付)しておくことができる(ステップS202,図4の(2))。仲介者10は治験依頼者12や治験実施者14から治験者募集の依頼を受け業務委受託契約などの手続が済むと(ステップS204、図4の(3))、ホームページ(HP)を改訂し新たな治験内容を追加提示する(ステップS206,図4の(4))。仲介者10はこの時事前受付(ステップS202)をした応募者(事前応募者)にHPが改訂されたことをメールで連絡し新しい(改訂された)HPを閲覧することを促す(ステップS207)。
(Subject recruitment procedure)
Next, the procedure for subject recruitment (step S110) will be described with reference to FIGS. The intermediary 10 regularly presents the recruitment of subjects on the homepage (HP) (step S200 in FIG. 3). Therefore, the applicant can confirm this ((1) in FIG. 4), apply in advance and register (pre-acceptance) (step S202, (2) in FIG. 4). When the intermediary 10 receives a request for investigators from the clinical trial client 12 or the clinical trial practitioner 14 and completes a procedure such as a business consignment contract (step S204, (3) in FIG. 4), the intermediary 10 revises the homepage (HP). New clinical trial contents are additionally presented (step S206, (4) in FIG. 4). The broker 10 informs the applicant (pre-applicant) who has received the advance reception (step S202) at this time by e-mail that the HP has been revised and prompts the user to view the new (revised) HP (step S207). .

なお治験実施者14と仲介者10との間のインターネット18を通したデータの送受信には、専用アプリケーションソフトを用いてセキュリティ機能を高めている。すなわち治験実施者14の端末機と仲介者10のサーバにはそれぞれ専用通信アプリケーションソフトを予め入力しておき、他の端末機では読出しできないようにする。また被験者16、仲介者10、治験実施者14の間のインターネット18を介したデータの送受には、一般的に用いられる暗号通信機能やID(個人認証)やPW(パスワード)などを用いてもよいのは勿論である。   In addition, in the transmission and reception of data through the Internet 18 between the trial investigator 14 and the mediator 10, the security function is enhanced by using dedicated application software. That is, dedicated communication application software is previously input to the terminal of the trial investigator 14 and the server of the intermediary 10, respectively, so that it cannot be read by other terminals. In addition, data transmission / reception between the subject 16, the mediator 10, and the trial investigator 14 via the Internet 18 may be performed using a commonly used encryption communication function, ID (personal authentication), PW (password), or the like. Of course it is good.

治験参加希望者(臨床試験参加希望者)がこの仲介者10の募集サイトを確認し(図4の(5))、応募すると(ステップS208)、仲介者10は参加希望の登録(応募登録)をする(ステップS210、図4の(6))。仲介者10はこの応募登録を経て参加条件を応募者16に送る(ステップS212、図4の(6))。この参加条件は治験の対象者、すなわち治験ルール、日程、地域、通院の可否などの条件である。   When a trial applicant (a clinical trial applicant) confirms the recruitment site of the mediator 10 ((5) in FIG. 4) and applies (step S208), the mediator 10 registers registration (application registration). (Step S210, (6) of FIG. 4). The broker 10 sends the participation condition to the applicant 16 through this application registration (step S212, (6) in FIG. 4). This participation condition is a subject of the clinical trial, that is, a clinical trial rule, a schedule, a region, whether or not to go to hospital.

応募者16はこの参加条件を見て参加の意志があれば参加申込みを行う(ステップS214、図4の(6))。参加申込みを受けて仲介者10は、さらに詳細条件を確認する(ステップS216、図4の(7))。この詳細条件確認は、図6、7、8の「参加条件」および除外条件に示す項目の質問を1つずつ行う。この際質問に対する回答があることを条件に次の質問に移るというように逐次的に行う。   Applicant 16 sees the participation conditions and applies for participation if there is an intention to participate (step S214, (6) in FIG. 4). Upon receiving the application for participation, the mediator 10 further confirms the detailed conditions (step S216, (7) in FIG. 4). In this detailed condition confirmation, questions of items shown in “participation conditions” and exclusion conditions in FIGS. At this time, it is performed sequentially such as moving to the next question on condition that there is an answer to the question.

なお応募者が他の質問に対する回答との矛盾点に気付いて前の回答を修正したり、前の回答を自ら参照して後の回答を正直に申告しないことが考えられる。しかし前の回答は後で修正することを不可能にしておくことにより、また前の質問は後で見直すことができないようにすることにより、正直な回答か否かを仲介者10側で判定することができる。このためには質問は1問ごとに異なるページに提示し、回答した質問は後で見直せないようにしておく。この結果精度の高い被験者の抽出が可能になる。   It is possible that the applicant notices inconsistencies with answers to other questions and corrects the previous answer, or does not refer to the previous answer himself and declare the later answer honestly. However, the intermediary 10 determines whether the previous answer is an honest answer by making it impossible to revise the previous answer later and by preventing the previous question from being reviewed later. be able to. For this purpose, each question is presented on a different page, and the answered question cannot be reviewed later. As a result, it is possible to extract subjects with high accuracy.

仲介者10のサーバではこのように一連の回答から矛盾点が無いか、正直な回答であるかを判定する(図4の(8))。以上の詳細条件確認の結果、参加可能か否かを判定しその結果(合否判定)を申込者に通知する(ステップS218、図4の(9))。また仲介者10は治験可能な応募者のリスト、すなわち被験候補者のリストを作成する(ステップS220、図4の(10))。治験実施者14はインターネット18を通して仲介者のサーバ10にアクセスしこの被験候補者のリストを閲覧し確認する(図4の(11))。このリストは、仲介者10から治験実施者14に他の方法、例えばeメールやファクシミリ、郵便などで送って閲覧可能にしてもよい。そして治験実施者14は予定の日時に来院する被験候補者16をこのリストに基づいて診察し、検診して治験に対する適否を最終的に判定する(図2のステップS112、図4の(12))。   The mediator 10 server determines whether there is no contradiction or an honest answer from the series of answers ((8) in FIG. 4). As a result of the above detailed condition confirmation, it is determined whether or not participation is possible, and the result (pass / fail determination) is notified to the applicant (step S218, (9) in FIG. 4). Further, the intermediary 10 creates a list of applicants who can conduct clinical trials, that is, a list of candidate candidates (step S220, (10) in FIG. 4). The investigator 14 accesses the intermediary server 10 through the Internet 18 and browses and confirms the list of candidate candidates ((11) in FIG. 4). This list may be sent from the intermediary 10 to the trial investigator 14 by other methods such as e-mail, facsimile, mail, etc. so that the list can be viewed. Then, the trial investigator 14 examines the candidate candidates 16 who visit the hospital on the scheduled date and time, and finally judges whether or not the trial candidate is appropriate (step S112 in FIG. 2, (12) in FIG. 4). ).

この検診の結果は集計して治験実施者14からeメールやファクシミリやインターネットを通して仲介者のサーバ10のデータを更新するなど適宜手段によって仲介者10に報告される(図2のステップS116、図4の(13))。この報告は被験者16から受けることもある。仲介者10はこの報告に基づいて被験者のリストを作成すると共に、治験候補者に通知する(図2のステップS118、図4の(14))。   The results of this examination are collected and reported to the mediator 10 by appropriate means such as updating the data of the mediator's server 10 via e-mail, facsimile, or the Internet from the trial investigator 14 (step S116 in FIG. 2, FIG. 4). (13)). This report may be received from the subject 16. The mediator 10 creates a list of subjects based on this report and notifies the trial candidates (step S118 in FIG. 2, (14) in FIG. 4).

合格した候補者に対して実施者14は治験を行い(図2のステップS120)、その結果が仲介者10に報告され(ステップS122)、仲介者10は料金を請求し(ステップS126、図4の(15))、治験結果を実施者14から受け取る(図4の(16))。   The practitioner 14 conducts a clinical trial for the successful candidate (step S120 in FIG. 2), the result is reported to the mediator 10 (step S122), and the mediator 10 charges a fee (step S126, FIG. 4). (15)), the clinical trial result is received from the practitioner 14 ((16) in FIG. 4).

なお図3のステップS220で行う被験候補者リストの作成においては、仲介者10は被験経験者についての実績データをサーバから読出し、該当する被験者16についての実績データを併記するのがよい。この実績データにより個々の被験者16の信頼性を確認することができ、信頼性の高い正直な参加者から得たデータを用いることにより治験結果の信頼性向上が図れるからである。   In the creation of the test candidate list performed in step S220 of FIG. 3, the intermediary 10 may read the performance data for the test experienced person from the server and write the performance data for the corresponding subject 16 together. This is because the reliability of the individual subject 16 can be confirmed from the result data, and the reliability of the clinical trial results can be improved by using data obtained from highly reliable and honest participants.

(サーバの構成)
次に図1に示した仲介者のサーバ10の構成を図5に基づいて説明する。このサーバ10は前記した処理を行うために、ソフトウェアで構成された種々の機能部を持つ。すなわち図3に示すステップS202、210、214に対応する応募受付部50、ステップS214に対応する参加申込み受付部52を持つ。
(Server configuration)
Next, the configuration of the mediator server 10 shown in FIG. 1 will be described with reference to FIG. The server 10 has various functional units configured by software in order to perform the above-described processing. That is, it has the application reception part 50 corresponding to step S202, 210, 214 shown in FIG. 3, and the participation application reception part 52 corresponding to step S214.

またステップS200、206に対応する募集画面表示部54、ステップS212に対応する参加条件提示部56、ステップS216に対応する詳細質問提示部58、ステップS216に対応する参加適否判定部60、ステップS220に対応するリスト作成部62および判定結果通知部64、過去および新しい被験経験者の実績データを記憶する実績データメモリ66、等を持つ。   In addition, the recruitment screen display unit 54 corresponding to steps S200 and 206, the participation condition presentation unit 56 corresponding to step S212, the detailed question presentation unit 58 corresponding to step S216, the participation suitability determination unit 60 corresponding to step S216, and step S220. A corresponding list creating unit 62 and determination result notifying unit 64, a record data memory 66 for storing record data of past and new test experienced persons, and the like.

本発明の一実施例を示す構成図The block diagram which shows one Example of this invention その全体動作の流れ図Flow chart of overall operation 被験者募集動作の流れ図Flow chart of subject recruitment operations 同じく信号・データの送受を示す図Figure showing signal and data transmission / reception 仲介者のサーバの構成図Mediation server configuration diagram 詳細質問(参加条件と除外条件)の例を示す図Diagram showing examples of detailed questions (participation conditions and exclusion conditions) 詳細質問(参加条件と除外条件)の例を示す図Diagram showing examples of detailed questions (participation conditions and exclusion conditions) 詳細質問(参加条件と除外条件)の例を示す図Diagram showing examples of detailed questions (participation conditions and exclusion conditions)

符号の説明Explanation of symbols

10 仲介者(のサーバ)
12 治験依頼者(の端末機)
14 治験実施者(の端末機)
16 被験希望者または応募者(の端末機)
18 インターネット
10 Broker (server)
12 Clinical trial client (terminal)
14 Clinical trial operator (terminal)
16 Applicant or applicant (terminal)
18 Internet

Claims (9)

治験実施者が行う治験に協力する被験者を紹介する仲介者が、インターネットを介して被験者を募集するための被験者募集方法において、前記仲介者のサーバは、
a.仲介者が募集内容を示す募集画面をインターネットを介して提示し治験参加希望者に登録を促す工程、
b.応募者の登録を受けて応募者に治験条件を提示し参加申込みを促す工程、
c.応募者の参加申込みを受けて応募者に治験に対応する詳細な質問を逐次形式で提示しその回答を受けると共に前の回答を修正不可とする動作を1つの質問ごとに逐次繰り返す工程、
d.応募者が前記治験に適合するか否かを判定しその結果から治験候補者のリストを作成し治験実施者による閲覧を可能にする工程、
e.前記工程dの判定結果を参加申込者に連絡する工程、
以上のa〜eの工程を有する被験者募集方法。
In the subject recruiting method for recruiting a subject via the Internet by an intermediary who introduces a subject who cooperates in a clinical trial conducted by a trial investigator, the mediator's server includes:
a. A process in which an intermediary presents a recruitment screen showing the recruitment content via the Internet and prompts the prospective applicant to register;
b. The process of receiving applicant registration and presenting the clinical trial conditions to the applicant and encouraging participation application,
c. The process of receiving the applicant's participation application and presenting detailed questions corresponding to the clinical trial to the applicant in a sequential format and receiving the answers, and repeating the operation of making the previous answer uncorrectable for each question,
d. Determining whether the applicant is suitable for the clinical trial, creating a list of clinical trial candidates from the results, and allowing the trial investigator to view it,
e. A step of notifying the participation applicant of the determination result of step d;
A subject recruiting method comprising the above steps a to e.
仲介者のサーバは、被験経験者の実績を示すデータを記憶するメモリを持ち、前記工程dで作成するリストにこの実績データに基づいた信頼性情報を合わせて出力する請求項1の被験者募集方法。   The method for recruiting subjects according to claim 1, wherein the server of the intermediary has a memory for storing data indicating the results of the test experienced person, and outputs reliability information based on the result data to the list created in the step d. . 請求項1の工程cにおいて、詳細な質問は治験応募者の端末機に1問ごとに別画面として表示され、1問ごとの回答を待って次の質問の表示に移行する請求項1の被験者募集方法。   In step c of claim 1, the detailed question is displayed as a separate screen for each question on the trial applicant's terminal, and the next question is displayed after waiting for an answer for each question. Recruitment method. 請求項1の工程cは、応募者に対して予め用意した詳細な質問を途中で中断することなく最後まで行う請求項1の被験者募集方法。   Step c of claim 1 is a method for recruiting subjects according to claim 1, wherein a detailed question prepared in advance for an applicant is performed to the end without interruption. 請求項1の工程eでは、判定結果を予め決めた一定時間以上経過後に参加申込者に連絡する請求項1の被験者募集方法。   The method for recruiting subjects according to claim 1, wherein, in step e of claim 1, the participant is notified after elapse of a predetermined time or more as a result of determination. 請求項1の方法に用いる仲介者のサーバであって、
被験参加希望者の端末機に対し治験条件を示す治験者募集画面を提示し応募を促す募集画面提示部と、
被験参加希望者の端末機から入力される登録申込信号を受付ける登録受付部と、
登録申込信号を受け付けて治験参加希望者である応募者の端末機に治験条件を提示し治験参加を促す参加条件提示部と、
応募者の端末機から入力される治験参加申込信号を受付ける参加申込み受付部と、
参加申込信号を受け付けて治験に対応する詳細な質問を応募者の端末機に逐次形式で提示し回答を促すと共に前の回答を修正不可とする詳細質問提示部と、
応募者が治験に適合するか否かを判定する適否判定部と、
適合する応募者を被験候補者としてリストを作成し治験実施者による閲覧を可能にするリスト作成部と、
前記適否判定部の判定結果を各治験参加申込者ごとにそれぞれ通知する判定結果通知部と、
を備えることを特徴とする被験者募集仲介者のサーバ。
An intermediary server used in the method of claim 1,
A recruitment screen presentation unit that presents an investigator recruitment screen showing the trial conditions to the terminal of the applicant who wishes to participate,
A registration accepting unit that accepts a registration application signal input from a terminal of a test applicant,
A participation condition presentation unit that accepts a registration application signal and presents the clinical trial conditions on the terminal of the applicant who is the applicant for the clinical trial,
Participation application reception part that accepts the clinical trial participation application signal input from the applicant's terminal,
A detailed question presentation unit that accepts a participation application signal and presents detailed questions corresponding to the clinical trial on the terminal of the applicant in a sequential format to prompt answers and make the previous answer uncorrectable;
A suitability determination unit that determines whether the applicant is suitable for the clinical trial,
A list creation unit that creates a list with suitable applicants as test candidates and allows the trial investigator to view the list,
A determination result notifying unit for notifying the determination result of the suitability determining unit for each clinical trial participation applicant,
A server for recruiting intermediaries for subjects.
請求項6において、さらに被験経験者の実績を示すデータを記憶するメモリを持ち、リスト作成部は被験候補者のリストに被験経験者の実績データを併せて表示する被験者募集仲介者のサーバ。   7. The subject recruitment intermediary server according to claim 6, further comprising a memory for storing data indicating the results of the test experienced person, wherein the list creation unit displays the test experienced person's result data together with the test candidate list. 請求項1の動作を行うためのソフトウェア。   Software for performing the operation of claim 1. 請求項8のソフトウェアを記憶した記憶媒体。   A storage medium storing the software of claim 8.
JP2006355661A 2006-12-28 2006-12-28 Subject recruitment method, mediator server, software, recording medium Active JP4697972B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006355661A JP4697972B2 (en) 2006-12-28 2006-12-28 Subject recruitment method, mediator server, software, recording medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006355661A JP4697972B2 (en) 2006-12-28 2006-12-28 Subject recruitment method, mediator server, software, recording medium

Publications (2)

Publication Number Publication Date
JP2008186039A true JP2008186039A (en) 2008-08-14
JP4697972B2 JP4697972B2 (en) 2011-06-08

Family

ID=39729079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006355661A Active JP4697972B2 (en) 2006-12-28 2006-12-28 Subject recruitment method, mediator server, software, recording medium

Country Status (1)

Country Link
JP (1) JP4697972B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011233066A (en) * 2010-04-30 2011-11-17 Huma Corp Subject recruitment method, server of intermediary, software, and recording medium
JP6262908B1 (en) * 2017-06-09 2018-01-17 リーズンホワイ株式会社 Medical system and medical program
US20200381088A1 (en) * 2018-01-12 2020-12-03 Industrial Cooperation Foundation Chonbuk National University Method and system for clinical trial resource management using block chain
KR102186179B1 (en) * 2020-07-28 2020-12-03 박성진 Drug test intermediary system for dual application of clinical trial and bioactivity test

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09242978A (en) * 1996-03-05 1997-09-16 Hirano:Kk Terminal treating plug of embedded pipe
JPH1185727A (en) * 1997-09-08 1999-03-30 Nippon Telegr & Teleph Corp <Ntt> Inspecting method for electronic survey through communication network and device used for the same
JP2001282959A (en) * 2000-03-31 2001-10-12 The Solution Consulting Kk Consulting method and consulting system
JP2002073933A (en) * 2000-08-25 2002-03-12 Nec Corp Temporary employment system using network
JP2002183371A (en) * 2000-12-11 2002-06-28 Casio Comput Co Ltd Device and method of executing questionnaire, and recording medium
JP2003150697A (en) * 2001-11-15 2003-05-23 Shogyo Kaihatsu Kenkyusho:Kk Appropriate job judgement system and server equipment
JP2004185067A (en) * 2002-11-29 2004-07-02 Wellness:Kk Subject suitableness deciding system
WO2004070639A1 (en) * 2003-02-04 2004-08-19 Ginganet Corporation Remote interview exam system

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09242978A (en) * 1996-03-05 1997-09-16 Hirano:Kk Terminal treating plug of embedded pipe
JPH1185727A (en) * 1997-09-08 1999-03-30 Nippon Telegr & Teleph Corp <Ntt> Inspecting method for electronic survey through communication network and device used for the same
JP2001282959A (en) * 2000-03-31 2001-10-12 The Solution Consulting Kk Consulting method and consulting system
JP2002073933A (en) * 2000-08-25 2002-03-12 Nec Corp Temporary employment system using network
JP2002183371A (en) * 2000-12-11 2002-06-28 Casio Comput Co Ltd Device and method of executing questionnaire, and recording medium
JP2003150697A (en) * 2001-11-15 2003-05-23 Shogyo Kaihatsu Kenkyusho:Kk Appropriate job judgement system and server equipment
JP2004185067A (en) * 2002-11-29 2004-07-02 Wellness:Kk Subject suitableness deciding system
WO2004070639A1 (en) * 2003-02-04 2004-08-19 Ginganet Corporation Remote interview exam system

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011233066A (en) * 2010-04-30 2011-11-17 Huma Corp Subject recruitment method, server of intermediary, software, and recording medium
JP6262908B1 (en) * 2017-06-09 2018-01-17 リーズンホワイ株式会社 Medical system and medical program
JP2018206287A (en) * 2017-06-09 2018-12-27 リーズンホワイ株式会社 Medical system and medical program
US20200381088A1 (en) * 2018-01-12 2020-12-03 Industrial Cooperation Foundation Chonbuk National University Method and system for clinical trial resource management using block chain
KR102186179B1 (en) * 2020-07-28 2020-12-03 박성진 Drug test intermediary system for dual application of clinical trial and bioactivity test

Also Published As

Publication number Publication date
JP4697972B2 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
Elwy et al. Using formative evaluation methods to improve clinical implementation efforts: Description and an example
US20080133270A1 (en) Systems and Methods for Selecting and Recruiting Investigators and Subjects for Clinical Studies
JP5073008B2 (en) Subject recruitment method, mediator server, software, recording medium
WO2001055942A1 (en) Systems and methods for selecting and recruiting investigators and subjects for clinical studies
Whitehead Evaluating health promotion: a model for nursing practice
Bailey et al. Early Check: translational science at the intersection of public health and newborn screening
Pascoe et al. “Patients are not the same, so we cannot treat them the same”–A qualitative content analysis of provider, patient and implementer perspectives on differentiated service delivery models for HIV treatment in South Africa
Willner et al. Knowledge of mental capacity issues in community teams for adults with learning disabilities
Sweeney et al. Development of the Irish National patient perception of quality of care survey
JP4697972B2 (en) Subject recruitment method, mediator server, software, recording medium
Brown et al. Surgical safety checklist audits may be misleading! Improving the implementation and adherence of the surgical safety checklist: a quality improvement project
Akerele et al. Improving routine immunization data quality using daily short message system reporting platform: An experience from Nasarawa state, Nigeria
Bucknall et al. Evidence based practices are critical care nurses ready for it?
Nkwawir et al. From grass to grace: how SLMTA revolutionised the Bamenda regional hospital laboratory in Cameroon
JP2012248005A (en) Clinical trial guide method, server of intermediary, software, and recording medium
Myers et al. Ontario men's survey
Senkowski et al. A review of the effectiveness of HIV sexual risk prevention interventions in adult prison inmates
Yang et al. Issues in evaluating the user performance of new home medical devices: a field test of two devices produced by a leading provider
Auriacombe Survey research: critical considerations for questionnaire construction
Kurzydlo et al. Reducing professional isolation: Support scheme for rural specialists
Reddy et al. Use of clinical guidelines in remote australia: A realist evaluation
Dana et al. Engaging Black or African American and Hispanic or Latino men who have sex with men for HIV testing and prevention services through technology: Protocol for the iSTAMP Comparative Effectiveness Trial
Khodyakov et al. RAND methodological guidance for conducting and critically appraising Delphi panels
Gupta et al. An Approach to Consumer Feedback in an Out‐patient Specialty Service
Kevany et al. Global health diplomacy, monitoring & evaluation, and the importance of quality assurance & control: findings from NIMH project accept (HPTN 043): A Phase III randomized controlled trial of community mobilization, mobile testing, same-day results, and post-test support for HIV in Sub-Saharan Africa and Thailand

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080718

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20080819

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20080919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110228

R150 Certificate of patent or registration of utility model

Ref document number: 4697972

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250